Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法,那么请第一时间了解新见解,与我们一起推动科学发展。
案例研究
Latest case studies
Popular case studies
All case studies

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

63 次迭代仍未收敛:When RsNLME succeeded where other PK/PD solutions couldn’t

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection

Accelerated ADC Approval Through Expert Modeling and Data Rescue




